AI assistant
Structure Therapeutics Inc. — Director's Dealing 2023
Dec 7, 2023
31940_dirs_2023-12-07_0facfbea-ee38-4bec-a7f5-bb622189a6f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-12-05
Reporting Person: FMR LLC (10% Owner, See Remark 1)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-12-05 | American Depositary Shares | $ | S | 1368 | Disposed | Ordinary Shares (4104) | Indirect | |
| 2023-12-05 | American Depositary Shares | $ | S | 16086 | Disposed | Ordinary Shares (48258) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 45120 | Indirect |
| Ordinary Shares | 530814 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| American Depositary Shares | $ | Ordinary Shares (4769400) | 1589800 | Indirect | |
| American Depositary Shares | $ | Ordinary Shares (123) | 41 | Indirect |
Footnotes
F1: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.
F2: The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $62.35 to $62.63. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.